Nippon Life Global Investors Americas Inc. Boosts Stake in CVS Health Corporation $CVS

Nippon Life Global Investors Americas Inc. boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 22.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,250 shares of the pharmacy operator’s stock after acquiring an additional 16,650 shares during the period. Nippon Life Global Investors Americas Inc.’s holdings in CVS Health were worth $6,729,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Focus Financial Network Inc. grew its holdings in CVS Health by 3.2% in the 2nd quarter. Focus Financial Network Inc. now owns 11,438 shares of the pharmacy operator’s stock valued at $789,000 after buying an additional 357 shares in the last quarter. Signal Advisors Wealth LLC purchased a new stake in shares of CVS Health in the second quarter valued at about $227,000. Baader Bank Aktiengesellschaft increased its position in CVS Health by 62.8% during the second quarter. Baader Bank Aktiengesellschaft now owns 6,253 shares of the pharmacy operator’s stock worth $430,000 after purchasing an additional 2,411 shares during the last quarter. Secure Asset Management LLC purchased a new position in CVS Health during the second quarter worth about $204,000. Finally, Wedmont Private Capital grew its stake in shares of CVS Health by 9.7% in the 2nd quarter. Wedmont Private Capital now owns 12,191 shares of the pharmacy operator’s stock valued at $813,000 after buying an additional 1,081 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on CVS. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Evercore ISI lifted their target price on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Argus increased their price target on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. TD Cowen boosted their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $94.86.

CVS Health Stock Down 3.5%

Shares of NYSE CVS opened at $78.51 on Friday. The stock has a market cap of $99.66 billion, a P/E ratio of 206.61, a PEG ratio of 0.72 and a beta of 0.48. The business’s fifty day simple moving average is $78.84 and its 200-day simple moving average is $74.29. CVS Health Corporation has a 12-month low of $51.79 and a 12-month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter last year, the business posted $1.09 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.